The RSV prefusion F vaccine reduced hospitalization for RSV-related respiratory tract disease in older adults compared to no vaccine.
Does RSV prefusion F vaccine reduce hospitalization for RSV-related respiratory tract disease in older adults?
In older adults, the RSV prefusion F vaccine reduces hospitalizations for RSV-related respiratory tract disease compared to no vaccine.
Absolute Event Rate: 0% vs 0%
GIM/FP/GP: Formula: see text Geriatrics: Formula: see text Infectious Disease: Formula: see text Pulmonology: Formula: see text.
Sacks et al. (Mon,) reported a other. The RSV prefusion F vaccine reduced hospitalization for RSV-related respiratory tract disease in older adults compared to no vaccine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: